← Leaderboards
Heidi J Crayton
Children'S Research Institute
$82,891
Attributed
$82,891
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.1K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$82,891 · 6
By mechanism
M01$82,891 · 6
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Mark L Batshaw$21,890,139
- Linda Jones Herbert$2,265,624
- Robert J Freishtat$9,788,965
- Uta Lichter-Konecki$143,645
- Lori Luchtman-Jones$1,160,197
Research focus
Computer Retrieval Of Information On Scientific Projects DatabasePurposeFundingInstitutionResearch PersonnelResourcesSafetySourceGrantNatalizumabUnited States National Institutes Of HealthMonitorNeurologicRelapseRelapse /RecurrenceSymptomsTysabriMethodologyBlood TestsDrug Screening /EvaluationEarly DiagnosisExposure ToHypersensitivityImmunogenicity
Grant awards (6)
NATALIZUMAB HIGH TITER$16,410
M01 · FY2008 · RR · contact PI
EXTENSION STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF NATALIZUMAB FOLLOWING$8,899
M01 · FY2007 · RR · contact PI
SAFETY AND TOLERABILITY OF NATALIZUMAB IN SUBJECTS WITH MULTIPLE SCLEROSIS WHO H$21,684
M01 · FY2006 · RR · contact PI
AVONEX COMBINATION TRAIL (ACT)$16,004
M01 · FY2006 · RR · contact PI
A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER$13,424
M01 · FY2006 · RR · contact PI
AVONEX W/ ORAL METHOTREXATE, INTRAVENOUS METHYLPREDNISO$6,470
M01 · FY2005 · RR